Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saskia A. Cooke
Institution:
The Netherlands Cancer Institute
Observed institutions:
Guy's Hospital,
King's College London,
The Netherlands Cancer Institute
ORCID:
0000-0002-9549-5397
Observed ORCID:
0000-0002-9549-5397
OpenAlex ID:
A5090675948
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial
2023
·
Saskia A. Cooke
, Dirk de Ruysscher
, et al.
·
Radiotherapy and Oncology
·
58
PDF
Robust BRCA1‐like classification of copy number profiles of samples repeated across different datasets and platforms
2015
·
Philip C. Schouten
, Anita Grigoriadis
, et al.
·
Molecular Oncology
·
44
PDF
Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial
2025
·
Saskia A. Cooke
, José S.A. Belderbos
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
4
Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial
2024
·
Saskia A. Cooke
, José S.A. Belderbos
, et al.
·
Radiotherapy and Oncology
·
2
1594: Oesophageal toxicity in the phase 2 PET-Boost dose-escalation trial (NCT01024829) in LA-NSCLC
2024
·
Saskia A. Cooke
, José S.A. Belderbos
, et al.
·
Radiotherapy and Oncology
In Response to Arcidiacono et al.: “Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?”
2023
·
Saskia A. Cooke
, Jan-Jakob Sonke
, et al.
·
Radiotherapy and Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
108
H-index:
3
I10-index:
2
Year
Topic
Type